
|Videos|January 14, 2022
Dupilumab in Atopic Dermatitis and What Pharmacists Should Know
It is important for pharmacists to know the latest updates on the right treatment options for atopic dermatitis.
Advertisement
Pharmacy Times spoke with Dr. Peter Lio, assistant professor of dermatology & pediatrics at Northwestern University Feinberg School of Medicine, about dupilumab associated Ocular Surface Disease in patients with atopic dermatitis.
Dr. Lio discussed what drew him and his team into the topic of dupilumab for studies about atopic dermatitis and any significant findings that pharmacists should know when counseling their patients.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
2
The ABCs of Vitamin D Supplements: Exploring Their Health Benefits and Proper Use
3
FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis
4
Occupational Factors Can Increase Risk of Long COVID
5




































































































































































































